NNovo Nordisk Read More Novo Nordisk: Oral Wegovy Approval Buoys Stock, but Pipeline Data Highlights Lilly’s Lead2026-06-12 The UK’s drugs regulator has handed Novo Nordisk a strategic win for its oral version of Wegovy, giving…